argenx SE reported $4.25B of revenue over the trailing twelve months, +688% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.25B (to FY2025). Net Income: $1.29B, trailing twelve months to FY2025. Free Cash Flow: $679M, trailing twelve months to FY2025. Op Margin: 25%, trailing twelve months to FY2025.

ARGXargenx SE

HealthcareUSD

$1,046.73

$637.5652 weeks$1.0K

ARGX as reported

argenx SE reported $4.25B of revenue over the trailing twelve months, +688% on the year before. 10 reported series are charted on this page, each one as filed.

$4.25B

Revenue, trailing twelve months · to FY2025 · +688% against the twelve months before

Net Income: $1.29B
Net Income · −416% year on year · trailing twelve months to FY2025
Free Cash Flow: $679M
Free Cash Flow · −211% year on year · trailing twelve months to FY2025
Op Margin: 25%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for ARGX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.25B	+688%	FY2025
Net Income	$1.29B	−416%	FY2025
EPS	$19.57	−345%	FY2025
Gross Margin	89%	n/a	FY2025
Op Margin	25%	n/a	FY2025
Net Margin	30%	n/a	FY2025
ROE	18%	n/a	FY2025
ROA	15%	n/a	FY2025
Free Cash Flow	$679M	−211%	FY2025
P/E	53.5	n/a	today